ROCK2 and glioblastoma: ShRNA was used to downregulate ROCK1 and ROCK2 expressions in the D54MG and 86HG39 glioblastoma cell lines, and the effects on cell migration, proliferation, substrate-dependent migration, and signaling pathways were compared.